Marinomed Biotech AG hereby announces that due to the further exercise of stock options from the current employee stock option plan the total number of voting rights at the end of January 2021 has increased to 1,474,731 and the new stated capital amounts to EUR 1,474,731. The change of total voting rights has been effective since January 18, 2021.
Marinomed Biotech AG
Pascal Schmidt, CFO
phone: +43 2262 90300
ISIN(s): ATMARINOMED6 (share)
stock exchanges: official trade in Vienna